C07D 239/69
Benzenesulfonamido-pyrimidines
C07D239/69 (Benzenesulfonamido-pyrimidines) appears on 110 US grants and 98 published applications in this corpus.
Search patents in C07D- Granted patents
- 110
- Published applications
- 98
- Assignees
- 85
- Inventors
- 398
- Latest grant
- 24 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 2 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 2 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 2 | 0 |
| 1996 | 3 | 0 |
| 1997 | 4 | 0 |
| 1998 | 3 | 0 |
| 1999 | 8 | 0 |
| 2000 | 2 | 0 |
| 2001 | 0 | 0 |
| 2002 | 2 | 3 |
| 2003 | 3 | 3 |
| 2004 | 0 | 2 |
| 2005 | 2 | 3 |
| 2006 | 1 | 3 |
| 2007 | 1 | 1 |
| 2008 | 1 | 0 |
| 2009 | 4 | 4 |
| 2010 | 0 | 6 |
| 2011 | 2 | 7 |
| 2012 | 4 | 5 |
| 2013 | 5 | 8 |
| 2014 | 7 | 4 |
| 2015 | 7 | 5 |
| 2016 | 3 | 4 |
| 2017 | 4 | 3 |
| 2018 | 2 | 4 |
| 2019 | 5 | 4 |
| 2020 | 4 | 5 |
| 2021 | 2 | 6 |
| 2022 | 6 | 6 |
| 2023 | 2 | 6 |
| 2024 | 2 | 2 |
| 2025 | 4 | 0 |
| 2026 | 1 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- 6-membered heteroarylaminosulfonamides for treating diseases and conditions mediated by deficient CFTR activity24 Mar 2026US 12,583,824 B2Genzyme Corporation
- Property modulation with chemical transformations16 Dec 2025US 12,497,712 B2The Regents of the University of Michigan
- Cystic fibrosis transmembrane conductance regulator modulating agents23 Sep 2025US 12,421,251 B2Vertex Pharmaceuticals Incorporated
- IRE1 small molecule inhibitors2 Sep 2025US 12,404,248 B2Cornell University
- 4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channels11 Mar 2025US 12,246,008 B2Merck Sharp & Dohme Corp.
- Heterobifunctional compounds and methods of treating disease11 Jun 2026US 2026/0159520 A1Halda Therapeutics OpCo, Inc.
- Sirtuin modulating compounds, including sirtuin activating compounds, and applications thereof23 Apr 2026US 2026/0109713 A1
- Method for synthesizing sulfamonomethoxine5 Feb 2026US 2026/0035350 A1Nanhai Beisha Pharmaceutical Co., Ltd.
- Synthetic method of sulfamerazine5 Feb 2026US 2026/0035351 A1Nanhai Beisha Pharmaceutical Co., Ltd.
- Ire1 small molecule inhibitors29 Aug 2024US 2024/0287004 A1Cornell University
Most cited
By later US patents
- Sulfonamides104US 5,292,740 AHoffmann-La Roche Inc. · 1994
- Phenylsulfonylamide pyrimidine84US 5,420,129 AHoffmann-La Roche Inc. · 1995
- Sulfonamides and uses69US 5,270,313 AHoffmann-La Roche Inc. · 1993
- Sulfonylaminopyrimidines49US 5,541,186 AHoffmann-La Roche Inc. · 1996
- Benzenesulfonamide derivative and process for preparing thereof48US 5,589,478 ATanabe Seiyaku Co., Ltd. · 1996